文献速递乳腺癌放疗胸部肿瘤放疗

隐匿性COVID-19:无症状放疗患者锥形束CT的肺部改变

Covert COVID-19: Cone Beam Computed Tomography Lung Changes in an Asymptomatic Patient Receiving Radiation Therapy.
PubMed 文献 · Adv Radiat Oncol · 2020-05-19

本文报告一名最初无症状的乳腺癌患者在接受图像引导放疗期间,于放疗第二周出现COVID-19症状;回顾性复习其每日锥形束CT(CBCT)肺窗,发现症状出现前2天的第4、5次CBCT已见双肺外周磨玻璃影(GGO)。作者提示熟悉COVID-19肺炎的典型CT表现有助于在CBCT中早期识别,建议常规审阅肺窗。

要点

  • 放疗每日CBCT肺窗可在症状出现前发现双肺外周GGO。
  • 症状出现前2天的连续CBCT已见双肺外周GGO。
  • 建议常规审阅CBCT肺窗以辅助早期识别COVID-19肺炎。

核心结论

  • 熟悉COVID-19肺炎典型CT表现,可能使接受CBCT的放疗肿瘤患者获得早期检出。
  • 建议及时审阅CBCT肺窗以识别此类改变,期望症状前诊断带来更快的患者管理和减少 inadvertent 传播。

研究设计与样本

  • 回顾性复习1例最初无症状、接受图像引导放疗的乳腺癌患者的CBCT扫描,该患者在放疗第二周出现COVID-19症状。
  • 逐日CBCT肺窗与诊断放射科共同审阅,以筛查符合COVID-19的改变;康复时行诊断CT并与CBCT比较。

主要发现

  • 共回顾性审阅5次连续CBCT扫描。
  • 症状出现前2天的第4、5次CBCT见双肺外周GGO。
  • 放疗恢复当日CBCT显示GGO较无症状期扫描明显加重。
  • 诊断CT示双肺外周GGO及纵隔淋巴结肿大,提示COVID-19肺炎。
  • 3天后复查诊断CT肺部表现改善,患者顺利恢复放疗。

关键数值与推荐

  • COVID-19肺炎的影像学标志包括双肺外周磨玻璃影(GGO)和实变。
  • 本例第4、5次CBCT(症状出现前2天)见双肺外周GGO。

临床怎么用

  • 放疗期间审阅每日CBCT肺窗,警惕双肺外周GGO等COVID-19肺炎征象。
  • 对出现疑似影像改变者结合临床与诊断CT及时评估,以便尽早管理并减少传播。

局限性

  • 本文为单例回顾性报告,结论的推广需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: COVID-19 profoundly affected the United States, with New York City rapidly becoming the epicenter of the disease. Patients with cancer represent a vulnerable population in this pandemic, with data suggesting a higher risk for severe events and unfavorable outcomes. Timely identification of COVID-19 in patients with cancer has been thwarted by the limited availability of outpatient testing for SARS-CoV-2. Chest computed tomography (CT) plays a major role in the identification of COVID-19 pneumonia, with radiologic hallmarks including bilateral, peripheral ground-glass opacities (GGOs) and consolidation. Patients with cancer undergoing radiation therapy (RT) commonly have daily cone beam computed tomography (CBCT) obtained for image-guided RT, and such imaging frequently includes the chest. METHODS AND MATERIALS: We retrospectively reviewed the CBCT scans of an initially asymptomatic patient undergoing image-guided RT for breast cancer who developed COVID-19 symptoms during the second week of RT. Lung windows of daily CBCT scans were reviewed with diagnostic radiology to survey for changes consistent with COVID-19. Diagnostic CT scans at the time of recovery were obtained and compared with the CBCTs. RESULTS: Five consecutive CBCT scans were retrospectively reviewed. Bilateral, peripheral GGOs were noted on the fourth and fifth CBCT scans in the 2 days before symptom onset. CBCT on the day of RT resumption demonstrated substantial worsening of the GGO compared with scans obtained during the asymptomatic phase. Diagnostic CTs demonstrated bilateral, peripheral GGOs and mediastinal lymphadenopathy, findings suggesting COVID-19 pneumonitis. Repeat diagnostic CT 3 days later showed improved pulmonary findings, and the patient resumed RT without incident. CONCLUSIONS: Familiarity with typical CT changes of COVID-19 pneumonitis may allow for early detection in cancer patients undergoing CBCT for RT treatment. Prompt review of the lung windows is recommended to identify such changes, with the hope that presymptomatic diagnosis leads to expedited patient management, improved outcomes, and a reduction of inadvertent COVID-19 dissemination.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Youssef I, Donahue B, Flyer M, et al. Covert COVID-19: Cone Beam Computed Tomography Lung Changes in an Asymptomatic Patient Receiving Radiation Therapy. Adv Radiat Oncol. 2020. PMID: 32775781. doi:10.1016/j.adro.2020.04.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。